[1]
T. H. Qasim, M. J. Ibraheem, and M. A.-. H. Jabarah, “Impact of sociodemographic characteristics and drug-related side effects on quality of life of patients with hepatocellular carcinoma receiving sorafenib treatment in Iraqi hospitals”, JFacMedBagdad, vol. 64, no. 4, pp. 286–291, Jan. 2023, doi: 10.32007/jfacmedbagdad.6442009.